ResearcherThe Cancer Institute HospitalNo recent work listed
Ikuhiro YAMADA
Matched on OpenAlex author ID A5031390643. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 35
2014: 2 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper
Papers 6
- FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study. Co-author DOI 10.1007/s00280-020-04206-w↗
- A Multicenter Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Elderly Patients With Advanced Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001484↗
- Improvement of Treatment Outcomes for Metastatic Pancreatic Cancer: A Real-world Data Analysis. Co-author DOI 10.21873/invivo.11471↗
- Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a sin… Co-author DOI 10.1093/jjco/hyu159↗
- Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-institutional case-control study in Japan. Co-author DOI 10.7314/apjcp.2014.15.1.391↗
- [FOLFIRINOX-induced hyperammonemic encephalopathy in a patient with pancreatic cancer]. Co-author PMID 25373377↗
Closest collaborators
The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masato Ozaka · 5 shared papers, 2014–2020 · strength 0.33
- Paper Improvement of Treatment Outcomes for Metastatic Pancreatic Cancer: A Real-world Data Analysis. DOI 10.21873/invivo.11471↗
- Paper A Multicenter Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Elderly Patients With Advanced Pancreatic Canc… DOI 10.1097/mpa.0000000000001484↗
- Paper Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer … DOI 10.1093/jjco/hyu159↗
- Masato Matsuyama · 4 shared papers, 2014–2019 · strength 0.25
- Paper Improvement of Treatment Outcomes for Metastatic Pancreatic Cancer: A Real-world Data Analysis. DOI 10.21873/invivo.11471↗
- Paper Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer … DOI 10.1093/jjco/hyu159↗
- Paper [FOLFIRINOX-induced hyperammonemic encephalopathy in a patient with pancreatic cancer]. PMID 25373377↗
- Makoto Ueno · 3 shared papers, 2014–2021 · strength 0.22
- Paper FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a mul… DOI 10.1007/s00280-020-04206-w↗
- Paper A Multicenter Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Elderly Patients With Advanced Pancreatic Canc… DOI 10.1097/mpa.0000000000001484↗
- Paper Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-instit… DOI 10.7314/apjcp.2014.15.1.391↗
- Takashi Sasaki · 2 shared papers, 2019–2020 · strength 0.20
- Naoki Sasahira · 2 shared papers, 2019–2020 · strength 0.20
- Kumiko Umemoto · 2 shared papers, 2020–2021 · strength 0.19
- Paper FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a mul… DOI 10.1007/s00280-020-04206-w↗
- Paper A Multicenter Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Elderly Patients With Advanced Pancreatic Canc… DOI 10.1097/mpa.0000000000001484↗
- Masafumi Ikeda · 2 shared papers, 2020–2021 · strength 0.19
- Paper FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a mul… DOI 10.1007/s00280-020-04206-w↗
- Paper A Multicenter Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Elderly Patients With Advanced Pancreatic Canc… DOI 10.1097/mpa.0000000000001484↗
- Hiroshi Ishii · 3 shared papers, 2014–2015 · strength 0.13
- Paper Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer … DOI 10.1093/jjco/hyu159↗
- Paper [FOLFIRINOX-induced hyperammonemic encephalopathy in a patient with pancreatic cancer]. PMID 25373377↗
- Paper Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-instit… DOI 10.7314/apjcp.2014.15.1.391↗
- Dai Inoue · 3 shared papers, 2014–2015 · strength 0.13
- Paper Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer … DOI 10.1093/jjco/hyu159↗
- Paper [FOLFIRINOX-induced hyperammonemic encephalopathy in a patient with pancreatic cancer]. PMID 25373377↗
- Paper Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-instit… DOI 10.7314/apjcp.2014.15.1.391↗
- Nobumasa Mizuno · 1 shared paper, 2021 · strength 0.11
- Takeshi Terashima · 1 shared paper, 2021 · strength 0.11
- Yukio Yoshida · 1 shared paper, 2021 · strength 0.11
- Junji Furuse · 1 shared paper, 2021 · strength 0.11
- Tetsuo Akimoto · 1 shared paper, 2021 · strength 0.11
- Masayo Motoya · 1 shared paper, 2021 · strength 0.11
- Chigusa Morizane · 1 shared paper, 2021 · strength 0.11
- Yuichiro Tozuka · 1 shared paper, 2020 · strength 0.08
- Shuichi Mitsunaga · 1 shared paper, 2020 · strength 0.08
- Satoshi Kobayashi · 1 shared paper, 2020 · strength 0.08
- Mitsuhito Sasaki · 1 shared paper, 2020 · strength 0.08
- Manabu Morimoto · 1 shared paper, 2020 · strength 0.08
- Hiroshi Imaoka · 1 shared paper, 2020 · strength 0.08
- Shun Tezuka · 1 shared paper, 2020 · strength 0.08
- Akio Saiura · 1 shared paper, 2015 · strength 0.06
- Masahiro Igarashi · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.